Hulamin (HLM)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 238.00 |
|---|---|
| 52-week range | 151.00 – 265.00 |
| Return, 1 month / 3 months | +5.8% / +39.2% |
| Return, 1 year / 3 years | −10.2% / −15.9% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 50.6% |
| Worst drawdown (1 year) | -40.4% |
| Average daily value traded | 63.41M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hulamin is a South African aluminium company based in Pietermaritzburg that makes rolled and extruded aluminium products. Its rolled products include sheet, plate and foil, while its extrusion business supplies shaped aluminium profiles. Customers come from packaging, automotive, construction and general engineering markets, and the company serves both domestic South African buyers and export customers. Hulamin converts aluminium into semi-finished products for manufacturers rather than making finished consumer goods.
Hulamin trades under the code HLM on the Johannesburg Stock Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hulamin (HLM) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 238.00 on 27 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 94 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.2% and over the last three months it rose 39.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 83 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.6% | ||
| From 52-week high | -10.2% | ||
| Momentum | 70 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 39.2% | ||
| 6-month return | 24.6% | ||
| 12-month return, skipping the last month | -15.1% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.4% | ||
| Liquidity | 36 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 63.41M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.7% |
|---|---|
| 1 month | +5.8% |
| 3 months | +39.2% |
| 6 months | +24.6% |
| 1 year | −10.2% |
| 3 years | −15.9% |
| 5 years | −40.5% |
Signals
| 50-day / 200-day average | 221.58 / 200.72 |
|---|---|
| Golden / death cross (60 days) | Golden, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Apr 2019 | ZAC 18.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.